Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

LONDON MARKET OPEN: FTSE 100 rises on lift from AstraZeneca results
29 Jul 2025

LONDON MARKET OPEN: FTSE 100 rises on lift from AstraZeneca results

(Alliance News) - Stock prices in London opened mixed on Tuesday, as an earnings boost at AstraZeneca was well received by investors and supported the...

AstraZeneca second quarter sales and profit boosted by cancer drugs
29 Jul 2025

AstraZeneca second quarter sales and profit boosted by cancer drugs

(Alliance News) - AstraZeneca PLC on Tuesday reported better-than-expected second quarter revenue, and raised its dividend, boosted by strong sales fr...

LONDON BRIEFING: AstraZeneca earnings increase; Greggs profit sinks
29 Jul 2025

LONDON BRIEFING: AstraZeneca earnings increase; Greggs profit sinks

(Alliance News) - AstraZeneca raised its dividend as drug growth pushed earnings higher, Barclays launched a new buyback programme after profit jumpe...

Astrazeneca H1 gross profits up 10pc as 'strong growth momentum' continues
29 Jul 2025

Astrazeneca H1 gross profits up 10pc as 'strong growth momentum' continues

(Sharecast News) - Drugmaker Astrazeneca said on Tuesday that "strong growth momentum" had continued in H1, with "excellent R&D pipeline delivery" in ...

London close: Stocks reverse gains to finish lower
28 Jul 2025

London close: Stocks reverse gains to finish lower

(Sharecast News) - London stocks ended lower on Monday, erasing earlier gains as investors reassessed the weekend's trade agreement between the United...

AstraZeneca's Imfinzi granted priority review for cancer forms in US
28 Jul 2025

AstraZeneca's Imfinzi granted priority review for cancer forms in US

(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has granted priority review for its immunotherapy drug Imfinzi for ...

AstraZeneca receives positive opinion from EMA for COPD therapy
25 Jul 2025

AstraZeneca receives positive opinion from EMA for COPD therapy

(Alliance News) - AstraZeneca PLC on Friday said its therapy for the treatment of chronic obstructive pulmonary disease in adults has received a posit...